“Acute angle-closure glaucoma”的搜索结果，显示 561-570 项，共有 11750 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

2. 心血管医学- 临床试验- 妙佑医疗国际

   ... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) ...

3. 外科 - 临床试验- 妙佑医疗国际

   ... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

7. 血液科- 临床试验- 妙佑医疗国际

   Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

8. 血液科- 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 血液科- 临床试验- 妙佑医疗国际

    Biorepository For Acute Leukemia Research ... acute leukemia (AML or ALL) for future biological studies. ... WeChat. Close. Weibo. 血液科. 科室首页; 部分. 概述 ...